AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy
in association with the AACR Cancer Immunology Working Group
October 1-4, 2023
The Westin Harbour Castle
Toronto, Ontario, Canada
Conference Cochairs:
Philip D. Greenberg, Fred Hutchinson Cancer Research Center, Seattle, Washington
Pamela S. Ohashi, UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York
Mario Sznol, Yale University, New Haven, Connecticut
This AACR Special Conference on Tumor Immunology and Immunotherapy was designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series has been to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. The 2023 program once again featured a roster of international thought-leaders who discussed new agent development, basic cancer immunobiology, engineering, target discovery, and translation of basic research to early clinical trial development. The conference began with an opening keynote lecture from Dr. Crystal L. Mackall from Stanford University who discussed T-cell engineering and CAR-T cell exhaustion. If you were unable to participate in Toronto, please register now to view the on-demand recordings available until December 13, 2023.
Supporters
Bristol Myers Squibb
Janssen
Professional Education Grants
Gilead
Novartis
Pfizer
